Free Trial
NYSE:CAH

Cardinal Health (CAH) Stock Price, News & Analysis

$98.37
+1.46 (+1.51%)
(As of 07/26/2024 ET)
Today's Range
$97.26
$98.84
50-Day Range
$93.74
$104.88
52-Week Range
$85.11
$116.04
Volume
1.38 million shs
Average Volume
2.16 million shs
Market Capitalization
$23.96 billion
P/E Ratio
43.72
Dividend Yield
2.05%
Price Target
$109.67

Cardinal Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.46 Rating Score
Upside/​Downside
11.5% Upside
$109.67 Price Target
Short Interest
Healthy
2.80% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.65
Upright™ Environmental Score
News Sentiment
0.64mentions of Cardinal Health in the last 14 days
Based on 17 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.72%
From $7.35 to $7.55 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.71 out of 5 stars

Medical Sector

62nd out of 936 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 6 stocks

CAH stock logo

About Cardinal Health Stock (NYSE:CAH)

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

CAH Stock Price History

CAH Stock News Headlines

J.P. Morgan’s DIRE Warning
When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."
Cardinal Health (NYSE:CAH) Upgraded by StockNews.com to "Strong-Buy"
Cardinal Health (NYSE:CAH) PT Lowered to $107.00
Cardinal Health: Growing Into The Valuation
J.P. Morgan’s DIRE Warning
When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."
See More Headlines
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/02/2024
Ex-Dividend for 7/15 Dividend
7/01/2024
Dividend Payable
7/15/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/14/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
CUSIP
14149Y10
Employees
48,000
Year Founded
1971

Price Target and Rating

Average Stock Price Target
$109.67
High Stock Price Target
$130.00
Low Stock Price Target
$90.00
Potential Upside/Downside
+11.5%
Consensus Rating
Hold
Rating Score (0-4)
2.46
Research Coverage
13 Analysts

Profitability

Net Income
$261 million
Pretax Margin
0.42%

Debt

Sales & Book Value

Annual Sales
$205.01 billion
Cash Flow
$8.83 per share
Book Value
($11.20) per share

Miscellaneous

Free Float
243,202,000
Market Cap
$23.96 billion
Optionable
Optionable
Beta
0.61

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

  • Cardinal Health's stock price is currently at an attractive level, providing a potential buying opportunity for investors.
  • The company has a consistent track record of increasing dividends, offering income-seeking investors a reliable source of passive income.
  • Cardinal Health operates as a healthcare services and products company in multiple regions, providing geographic diversification for investors.
  • Recent positive earnings results exceeding analyst expectations indicate strong financial performance and potential for growth.
  • Analyst consensus ratings leaning towards a "Moderate Buy" suggest positive sentiment and potential upside for the stock.

Cons

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

  • Cardinal Health's stock price has experienced recent fluctuations, indicating potential volatility and uncertainty in the market.
  • The company's negative return on equity and low net margin raise concerns about profitability and operational efficiency.
  • Market capitalization of $25.48 billion may limit potential for rapid stock price appreciation compared to smaller companies.
  • Decline in revenue compared to analyst expectations could signal challenges in the company's growth strategy.
  • High dividend payout ratio of 88.89% may limit reinvestment opportunities for the company and impact future growth potential.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, June 28, 2024. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

CAH Stock Analysis - Frequently Asked Questions

How have CAH shares performed this year?

Cardinal Health's stock was trading at $100.80 on January 1st, 2024. Since then, CAH shares have decreased by 2.4% and is now trading at $98.37.
View the best growth stocks for 2024 here
.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) released its earnings results on Thursday, May, 2nd. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $1.95 by $0.13. The firm's revenue was up 8.7% on a year-over-year basis.
Read the conference call transcript
.

What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

Does Cardinal Health have any subsidiaries?

Cardinal Health subsidiaries include Mscripts, Mirixa Corporation, Patient Recovery Business of Medtronic, TelePharm, RainTree Oncology Services, NaviHealth, Outcomes Incorporated, and others.

Who are Cardinal Health's major shareholders?

Top institutional shareholders of Cardinal Health include Bank of New York Mellon Corp (0.70%), Sumitomo Mitsui Trust Holdings Inc. (0.25%), Retirement Systems of Alabama (0.21%) and Swedbank AB (0.18%). Insiders that own company stock include Jessica L Mayer, Stephen M Mason, Deborah Weitzman, Ola M Snow, Mary C Scherer and Michelle Brennan.
View institutional ownership trends
.

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE) and Chevron (CVX).

This page (NYSE:CAH) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners